Wednesday, 23 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14475
Articles
Company
Deals
Salus Biomed Raises Over RMB 100M in Pre-Series A Financing
February 3, 2025
Company
Drug
Haisco Pharma’s Ciprofol Injection Gains NMPA Approval for Gynecology Use
February 3, 2025
Company
Drug
ScienCare Pharma’s Naltrexone Implant Prioritized for Review by CDE
February 3, 2025
Company
Drug
Grand Pharma’s TLX591-CDx Approved for Prostate Cancer Diagnosis in China
February 3, 2025
Company
Deals
Kunshi Biotechnology Raises Angel Funding for Engineered Macrophage Platform
February 3, 2025
Company
Drug
Akeso Biopharma’s Cadonilimab Recommended as First-Line Treatment for Cervical Cancer
February 3, 2025
Company
Drug
Fosun Kite’s Yescarta Gains Priority Review Status for r/r LBCL
February 3, 2025
Company
Drug
Genor Biopharma Initiates First Patient Dosing for GB263T in China
February 3, 2025
Company
Drug
Akeso Biopharma Gains NMPA Approval for AK112 and AK119 Clinical Study
February 3, 2025
Company
Drug
Innovent Biologics Publishes Mazdutide Phase Ib Study Results for Obesity
February 3, 2025
Company
Deals
Sihuan Pharma to Acquire Additional Stake in Heilongjiang Duoduo Pharma
February 3, 2025
Policy / Regulatory
NHSA Completes Expert Review for NRDL Price Negotiation Process
February 3, 2025
1
2
…
1,120
1,121
1,122
1,123
1,124
…
1,206
1,207
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?